Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
87,598,857
-
Share change
-
-275,467
-
Total reported value
-
$1,376,792,174
-
Put/Call ratio
-
470%
-
Price per share
-
$15.72
-
Number of holders
-
212
-
Value change
-
-$4,897,891
-
Number of buys
-
104
-
Number of sells
-
95
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2018
As of 30 Jun 2018,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
212 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,598,857 shares.
The largest 10 holders included
BlackRock Inc., FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, INGALLS & SNYDER LLC, Consonance Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Invesco Ltd., and DIMENSIONAL FUND ADVISORS LP.
This page lists
212
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.